TrialBlood2006

BCR-ABL mRNA levels at and after the time of a complete cytogenetic response (CCR) predict the duration of CCR in imatinib mesylate-treated patients with CML.

Richard D Press et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.